Treating infections with a new supramolecular delivery technology

At the brink of post-antibiotic era the growing threat of antimicrobial resistance (AMR) is one of the biggest threats to humankind with gram-negative bacteria being especially difficult due to the presence of outer membrane endowed with barrier properties. Health authorities have given multiple warnings about the looming dangers of AMR, highlighting the possible fall of modern medicine available. Furthermore, a weaker pipeline of new antibiotics and antimicrobials has diverted our attention towards supramolecular API delivery based technologies, which provide tremendous benefits upgrading the performance of APIs in several ways.

With several years of hard work and unlocking new discoverings, pharma scientists and engineers at Aalto Pharma developed safe, effective and sustainable solutions by combining APIs with an intelligent polymeric carrier to effectively fight topical infections.